Quantinno Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quantinno Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$56.5M	Buy	126,604 +34,320	+37%	+$16M	0.09%	243
2025 Q4	$41.8M	Buy	92,284 +36,643	+66%	+$15.8M	0.08%	262
2025 Q3	$21.8M	Buy	55,641 +9,319	+20%	+$3.89M	0.06%	389
2025 Q2	$20.6M	Buy	46,322 +7,897	+21%	+$3.64M	0.09%	249
2025 Q1	$18.6M	Buy	38,425 +14,349	+60%	+$6.69M	0.12%	167
2024 Q4	$9.7M	Buy	24,076 +4,381	+22%	+$2.03M	0.1%	212
2024 Q3	$9.16M	Buy	19,695 +5,238	+36%	+$2.52M	0.12%	154
2024 Q2	$6.78M	Buy	14,457 +1,692	+13%	+$734K	0.12%	147
2024 Q1	$5.34M	Buy	12,765 +1,896	+17%	+$802K	0.12%	174
2023 Q4	$4.42M	Buy	10,869 +1,494	+16%	+$552K	0.15%	126
2023 Q3	$3.26M	Buy	9,375 +1,804	+24%	+$631K	0.15%	144
2023 Q2	$2.66M	Buy	7,571 +3,754	+98%	+$1.26M	0.15%	153
2023 Q1	$1.2M	Sell	3,817 -164	-4%	-$49.2K	0.08%	324
2022 Q4	$1.15M	Buy	3,981 +2,573	+183%	+$784K	0.09%	319
2022 Q3	$408K	Buy	1,408 +250	+22%	+$71.9K	0.05%	421
2022 Q2	$326K	Buy	+1,158	New	+$310K	0.05%	438

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Quantinno Capital Management's VRTX Position: Q1 2026 in Review

Quantinno Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 37% in Q1 2026, buying an estimated $16M and bringing the position to 126,604 shares worth $56.5M. The position accounts for 0.09% of the portfolio, ranked #243.

Quantinno Capital Management first reported a position in VRTX in Q2 2022 and has held it in 16 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Quantinno Capital Management held 126,604 shares of Vertex Pharmaceuticals worth $56.5M as of Q1 2026.
Quantinno Capital Management bought 34,320 Vertex Pharmaceuticals shares in Q1 2026, an estimated $16M.
Vertex Pharmaceuticals made up 0.09% of Quantinno Capital Management's portfolio in Q1 2026, its #243 holding.
Quantinno Capital Management first reported a position in Vertex Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.